BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,302,000 | -13.2% | 10,985 | +0.9% | 0.04% | -22.2% |
| Q4 2021 | $1,500,000 | -76.7% | 10,885 | -85.5% | 0.05% | -76.9% |
| Q4 2020 | $6,428,000 | -63.9% | 75,000 | -77.1% | 0.23% | -85.1% |
| Q4 2019 | $17,802,000 | +25.5% | 327,000 | -3.8% | 1.57% | -35.4% |
| Q3 2019 | $14,185,000 | +8.0% | 340,000 | +13.3% | 2.42% | +21.5% |
| Q2 2019 | $13,137,000 | +750.8% | 300,000 | +900.0% | 2.00% | +806.8% |
| Q1 2019 | $1,544,000 | +14.9% | 30,000 | -42.5% | 0.22% | -72.3% |
| Q1 2018 | $1,344,000 | +18.1% | 52,186 | +23.7% | 0.79% | +66.8% |
| Q4 2017 | $1,138,000 | – | 42,186 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |